Cyberonics Promotes Rohan Hoare To COO - Quick Facts

(RTTNews) - Cyberonics Inc. (CYBX) announced that it promoted Rohan Hoare to the newly created role of Chief Operating Officer. As COO, Rohan will be responsible for the development, manufacturing, quality and commercial activities for the Epilepsy franchise.

Since joining Cyberonics in September 2013, Hoare has served as Senior Vice President, Strategic Planning, leading the company's business strategy development and execution. Formerly, he served as President of St. Jude Medical's Neuromodulation Division, which designs, manufactures and sells neuromodulation devices for the treatment of chronic pain, movement disorders and chronic migraine headache. He began his career with McKinsey & Co., a premiere strategy consulting firm, where he served clients in high tech, med tech and healthcare payor and providers for nearly a decade.

The company also announced that O'Neill F. D'Cruz, recently joined the company as Chief Medical Officer.

D'Cruz was most recently Medical Director, Neurology at UCB, S.A., and previously Professor of Neurology and Pediatrics at University of North Carolina-Chapel Hill. In addition to industry experience in clinical development, pharmacovigilance, regulatory interactions, public-private partnerships and business development, D'Cruz has worked in the field of epilepsy for over two decades, as a board-certified neurologist and epileptologist, health policy and patient advocate, clinical investigator and consultant to leading pharmaceutical companies.